Fig. 1From: Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancerKaplan–Meier curve for overall survival (OS) after docetaxel induction therapy. The median OS after docetaxel was 17.7 monthsBack to article page